The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2019
Filed:
Oct. 01, 2015
Applicant:
Arbutus Biopharma Corporation, Burnaby, CA;
Inventors:
Jennifer L. Cross, Delta, CA;
Ammen P. Dhillon, Delta, CA;
Amy C. H. Lee, Burnaby, CA;
Ian MacLachlan, Mission, CA;
Nicholas M. Snead, San Francisco, CA (US);
Emily P. Thi, Coquitlam, CA;
Assignee:
ARBUTUS BIOPHARMA CORPORATION, Burnaby, BC, CA;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/11 (2006.01); C12N 15/113 (2010.01); A61K 31/713 (2006.01); A61K 9/14 (2006.01); A61K 47/18 (2017.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1131 (2013.01); A61K 9/14 (2013.01); A61K 31/713 (2013.01); A61K 47/18 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); C12N 2310/14 (2013.01); C12N 2310/321 (2013.01); C12N 2310/323 (2013.01);
Abstract
The present invention provides compositions comprising therapeutic nucleic acids such as siRNA that target Hepatitis B virus (HBV) gene expression, lipid particles comprising one or more (e.g., a combination) of the therapeutic nucleic acids, and methods of delivering and/or administering the lipid particles (e.g., for treating HBV infection and/or HDV infection in humans).